Konstantinos N. Syrigos

Konstantinos N. Syrigos, MD, PhD is Professor of Medicine and Director of the Oncology Unit at Sotiria Hospital, Athens, affiliated with the National and Kapodistrian University of Athens School of Medicine. He is one of the most prolific and internationally recognized oncology researchers in Greece, with extensive expertise in the medical treatment of head and neck squamous cell carcinoma (HNSCC) as well as lung cancer. Dr. Syrigos has been a principal investigator or co-investigator for numerous European and multinational clinical trials in HNSCC, contributing patient cohorts and scientific expertise to studies of platinum-based chemotherapy, cetuximab-containing regimens, and, more recently, PD-1/PD-L1 checkpoint inhibitors. He has authored over 400 peer-reviewed publications and has been consistently ranked among the top-cited researchers in oncology from southeastern Europe. Dr. Syrigos has contributed to the clinical pharmacology of anticancer drugs in HNSCC and is known for translational studies examining predictive biomarkers including EGFR expression levels, K-RAS mutations, and tumor PD-L1 in the context of systemic therapies. He is a member of multiple ESMO and ASCO committees and serves on the editorial boards of leading oncology journals.